Literature DB >> 29518566

Abstinence to chronic methamphetamine switches connectivity between striatal, hippocampal and sensorimotor regions and increases cerebral blood volume response.

Ji-Kyung Choi1, Grewo Lim2, Yin-Ching Iris Chen3, Bruce G Jenkins4.   

Abstract

Methamphetamine (meth), and other psychostimulants such as cocaine, present a persistent problem for society with chronic users being highly prone to relapse. We show, in a chronic methamphetamine administration model, that discontinuation of drug for more than a week produces much larger changes in overall meth-induced brain connectivity and cerebral blood volume (CBV) response than changes that occur immediately following meth administration. Areas showing the largest changes were hippocampal, limbic striatum and sensorimotor cortical regions as well as brain stem areas including the pedunculopontine tegmentum (PPTg) and pontine nuclei - regions known to be important in mediating reinstatement of drug-taking after abstinence. These changes occur concomitantly with behavioral sensitization and appear to be mediated through increases in dopamine D1 and D3 and decreases in D2 receptor protein and mRNA expression. We further identify a novel region of dorsal caudate/putamen, with a low density of calbindin neurons, that has an opposite hemodynamic response to meth than the rest of the caudate/putamen and accumbens and shows very strong correlation with dorsal CA1 and CA3 hippocampus. This correlation switches following meth abstinence from CA1/CA3 to strong connections with ventral hippocampus (ventral subiculum) and nucleus accumbens. These data provide novel evidence for temporal alterations in brain connectivity where chronic meth can subvert hippocampal - striatal interactions from cognitive control regions to regions that mediate drug reinstatement. Our results also demonstrate that the signs and magnitudes of the induced CBV changes following challenge with meth or a D3-preferring agonist are a complementary read out of the relative changes that occur in D1, D2 and D3 receptors using protein or mRNA levels.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Functional connectivity; MRI; Receptor; Sensitization; methamphetamine

Mesh:

Substances:

Year:  2018        PMID: 29518566      PMCID: PMC5949272          DOI: 10.1016/j.neuroimage.2018.02.059

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  79 in total

1.  Community structure in networks of functional connectivity: resolving functional organization in the rat brain with pharmacological MRI.

Authors:  Adam J Schwarz; Alessandro Gozzi; Angelo Bifone
Journal:  Neuroimage       Date:  2009-04-02       Impact factor: 6.556

Review 2.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

3.  Basal Hippocampal Activity and Its Functional Connectivity Predicts Cocaine Relapse.

Authors:  Bryon Adinoff; Hong Gu; Carmen Merrick; Meredith McHugh; Haekyung Jeon-Slaughter; Hanzhang Lu; Yihong Yang; Elliot A Stein
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

Review 4.  The hippocampal-VTA loop: controlling the entry of information into long-term memory.

Authors:  John E Lisman; Anthony A Grace
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

5.  Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.

Authors:  C A Heidbreder; A C Thompson; T S Shippenberg
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

6.  Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior.

Authors:  Michela Andreoli; Michela Tessari; Maria Pilla; Enzo Valerio; Jim J Hagan; Christian A Heidbreder
Journal:  Neuropsychopharmacology       Date:  2003-04-16       Impact factor: 7.853

7.  Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data.

Authors:  Y C Chen; W R Galpern; A L Brownell; R T Matthews; M Bogdanov; O Isacson; J R Keltner; M F Beal; B R Rosen; B G Jenkins
Journal:  Magn Reson Med       Date:  1997-09       Impact factor: 4.668

8.  Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration.

Authors:  H Ujike; K Akiyama; H Nishikawa; T Onoue; S Otsuki
Journal:  Brain Res       Date:  1991-02-01       Impact factor: 3.252

9.  A receptor-based model for dopamine-induced fMRI signal.

Authors:  Joseph B Mandeville; Christin Y M Sander; Bruce G Jenkins; Jacob M Hooker; Ciprian Catana; Wim Vanduffel; Nathaniel M Alpert; Bruce R Rosen; Marc D Normandin
Journal:  Neuroimage       Date:  2013-03-01       Impact factor: 6.556

10.  A defined methodology for reliable quantification of Western blot data.

Authors:  Sean C Taylor; Thomas Berkelman; Geetha Yadav; Matt Hammond
Journal:  Mol Biotechnol       Date:  2013-11       Impact factor: 2.695

View more
  3 in total

1.  Chemogenetic inhibition of corticostriatal circuits reduces cued reinstatement of methamphetamine seeking.

Authors:  Angela M Kearns; Benjamin M Siemsen; Jordan L Hopkins; Rachel A Weber; Michael D Scofield; Jamie Peters; Carmela M Reichel
Journal:  Addict Biol       Date:  2021-08-25       Impact factor: 4.280

2.  Changes in ALFF and ReHo values in methamphetamine abstinent individuals based on the Harvard-Oxford atlas: A longitudinal resting-state fMRI study.

Authors:  Yanyao Du; Wenhan Yang; Jun Zhang; Jun Liu
Journal:  Addict Biol       Date:  2021-08-24       Impact factor: 4.093

3.  The Higher Parietal Cortical Thickness in Abstinent Methamphetamine Patients Is Correlated With Functional Connectivity and Age of First Usage.

Authors:  Ru Yang; Lei He; Zhixue Zhang; Wenming Zhou; Jun Liu
Journal:  Front Hum Neurosci       Date:  2021-08-30       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.